APA (7th ed.) Citation

Zaib, S., Munir, R., Younas, M. T., Kausar, N., Ibrar, A., Aqsa, S., . . . Khan, I. (2021). Hybrid Quinoline-Thiosemicarbazone Therapeutics as a New Treatment Opportunity for Alzheimer’s Disease‒Synthesis, In Vitro Cholinesterase Inhibitory Potential and Computational Modeling Analysis. MDPI AG.

Chicago Style (17th ed.) Citation

Zaib, Sumera, et al. Hybrid Quinoline-Thiosemicarbazone Therapeutics as a New Treatment Opportunity for Alzheimer’s Disease‒Synthesis, In Vitro Cholinesterase Inhibitory Potential and Computational Modeling Analysis. MDPI AG, 2021.

MLA (8th ed.) Citation

Zaib, Sumera, et al. Hybrid Quinoline-Thiosemicarbazone Therapeutics as a New Treatment Opportunity for Alzheimer’s Disease‒Synthesis, In Vitro Cholinesterase Inhibitory Potential and Computational Modeling Analysis. MDPI AG, 2021.